Q2 2013 Holdings
Filed 2013-08-14 | 17 holdings | $1.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.6M | 1,013,442 | 92.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $26.3K | 1,964,673 | 1.5% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $17.9K | 1,800,000 | 1.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $15.3K | 2,048,773 | 0.9% |
| Dyax Corp | COM | 26746E103 | $14.4K | 4,156,508 | 0.8% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $9.0K | 1,610,856 | 0.5% |
| Tesaro Inc | COM | 881569107 | $8.5K | 261,130 | 0.5% |
| GW Pharmaceuticals | COM | 36197T103 | $7.4K | 837,800 | 0.4% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $6.4K | 787,459 | 0.4% |
| Biodel Inc | COM | 09064M105 | $6.0K | 1,446,413 | 0.4% |
| Chelsea Therapeutics International Ltd | COM | 163428105 | $5.8K | 2,516,870 | 0.3% |
| Hyperion Therapeutics Inc | COM | 44915N101 | $5.6K | 255,000 | 0.3% |
| Threshold Pharmaceuticals Inc | COM | 885807206 | $3.6K | 684,000 | 0.2% |
| GTx Inc | COM | 40052B108 | $3.3K | 500,000 | 0.2% |
| Alexza Pharmaceuticals Inc | COM | 015384100 | $1.7K | 399,999 | 0.1% |
| Stemline Therapeutics Inc | COM | 85858C107 | $1.2K | 50,000 | 0.1% |
| Anthera Pharmaceuticals Inc | COM | 03674U102 | $666 | 1,437,623 | 0.0% |